🇺🇸 Topiramate add-on therapy in United States

Topiramate add-on therapy (Topiramate add-on therapy) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Topiramate add-on therapy in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Topiramate add-on therapy approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Topiramate add-on therapy in United States?

Johnson & Johnson Taiwan Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.